UNSPSC 51351633: Estrone sodium sulfate

This classification denotes an estrogen C18H21O5S.Na, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 6K6FDA543A, chemically known as estra-1,3,5(10)-trien-17-one, 3-(sulfooxy)-, sodium salt, but more generally known as estrone sodium sulfate, which bears US NIH Compound Identifier 23667301. European Medicines Agency schedules Estrone sodium sulfate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB01976MIG.

Most nations, for tariff and trade purposes, schedule estrone sodium sulfate under HS 29372300 and SITC 54153. As of Q4 2014, ESTRONE SODIUM SULFATE remains US FDA's Preferred Term for this commodity. Estrone sodium sulfate bears US NLM identifiers UMLS ID C0304783 and NCI Concept Code C61942. SMILES: C[C@]12CC[C@@H]3C4CCC(CC4CC[C@H]3[C@@H]1CCC2=O)OS(=O)(=O)[O-].[NA+].

UNSPSC 51351633 Estrone sodium sulfate is a Commodity code covering a synthetic estrogen compound used in veterinary medicine and animal health applications. State and local governments procure estrone sodium sulfate primarily through their animal control departments, public health agencies, and municipal animal shelters for use in spay and neuter programs and population management of stray or feral animals. The compound is typically purchased as a pharmaceutical injectable or oral formulation and is often bundled with other veterinary supplies and services in broader animal welfare or public health procurement initiatives.

The source provides no recent state and local contract opportunities under this code.